Top

Critical Care

Published in:

Open Access 01-02-2004 | Research

Effect of magnesium sulfate administration on blood–brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study

Authors: Figen Esen, Tulin Erdem, Damla Aktan, Mukadder Orhan, Mehmet Kaya, Haluk Eraksoy, Nahit Cakar, Lutfi Telci

Published in: Critical Care | Issue 1/2005

Abstract

Introduction

Permeability changes in the blood–brain barrier (BBB) and their possible contribution to brain edema formation have a crucial role in the pathophysiology of septic encephalopathy. Magnesium sulfate has been shown to have a protective effect on BBB integrity in multiple experimental models. In this study we determine whether magnesium sulfate administration could have any protective effects on BBB derangement in a rat model of sepsis.

Methods

This randomized controlled experimental study was performed on adult male Sprague–Dawley rats. Intraperitoneal sepsis was induced by using the infected fibrin–thrombin clot model. To examine the effect of magnesium in septic and sham-operated rats, a dose of 750 μmol/kg magnesium sulfate was given intramuscularly immediately after surgery. Control groups for both infected and sham-operated rats were injected with equal volume of saline. Those rats surviving for 24 hours were anesthetized and decapitated for the investigation of brain tissue specific gravity and BBB integrity by the spectrophotometric assay of Evans blue dye extravasations. Another set of experiments was performed for hemodynamic measurements and plasma magnesium level analysis. Rats were allocated into four parallel groups undergoing identical procedures.

Results

Sepsis significantly increased BBB permeability to Evans blue. The dye content of each hemisphere was significantly lower in the magnesium-treated septic rats (left hemisphere, 0.00218 ± 0.0005; right hemisphere, 0.00199 ± 0.0007 [all results are means ± standard deviation]) than in control septic animals (left hemisphere, 0.00466 ± 0.0002; right hemisphere, 0.00641 ± 0.0003). In septic animals treated with magnesium sulfate, specific gravity was higher (left hemisphere, 1.0438 ± 0.0007; right hemisphere, 1.0439 ± 0.0004) than in the untreated septic animals (left hemisphere, 1.0429 ± 0.0009; right hemisphere, 1.0424 ± 0.0012), indicating less edema formation with the administration of magnesium. A significant decrease in plasma magnesium levels was observed 24 hours after the induction of sepsis. The dose of magnesium that we used maintained the baseline plasma magnesium levels in magnesium-treated septic rats.

Conclusions

Magnesium administration attenuated the increased BBB permeability defect and caused a reduction in brain edema formation in our rat model of intraperitoneal sepsis.

Available only for authorised users

Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB: Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med 1990, 18: 801-806.CrossRefPubMed

Basler T, Meier-Helman A, Brele D, Reinhart K: Amino acid imbalance early in septic encephalopathy. Intensive Care Med 2002, 28: 293-298. 10.1007/s00134-002-1217-6CrossRefPubMed

Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED: Faecal peritonitis causes edema and neuronal injury in pig cerebral cortex. Clin Sci 1999, 96: 461-466. 10.1042/CS19980327CrossRefPubMed

Kaya M, Küçük M, Bulut Kalayci R, Cimen V, Gürses C, Elmas I, Arican N: Magnesium sulfate attenuates increased blood–brain barrier permeability during insulin-induced hypoglycemia in rats. Can J Physiol Pharmacol 2001, 79: 793-798. 10.1139/cjpp-79-9-793CrossRefPubMed

Esen F, Erdem T, Aktan D, Kalaycý R, Cakar N, Kaya M, Telci L: Effects of magnesium administration on brain edema and blood brain barrier breakdown after experimental traumatic brain injury in rats. J Neurosurg Anesthesiol 2003, 15: 119-125. 10.1097/00008506-200304000-00009CrossRefPubMed

Heath DL, Vink R: Neuroprotective effects of MgSO4 and MgC12 in closed head injury: a comparitive phosphorus NMR study. J Neurotrauma 1998,15(3):183-189.CrossRefPubMed

Heath DL, Vink R: Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury. J Neurosurg 1999, 90: 504-509.CrossRefPubMed

Mathiak G, Szwczyk D, Abdullah F, Ovadia P, Feuerstein G, Rabinovici R: An improved clinically relevant sepsis model in the conscious rat. Crit Care Med 2000, 28: 1947-1952. 10.1097/00003246-200006000-00043CrossRefPubMed

Mikawa S, Kinouchi H, Kamii H, Gobbell GT, Chen SF, Carlson E, Epstein CJ, Chan PH: Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-super oxide dismutase transgenic mice. J Neurosurg 1996, 85: 885-891.CrossRefPubMed

10.

Marmarou A, Poll W, Shulman K, Bhagavan H: A simple gravimetric technique for measurement of cerebral edema. J Neurosurg 1978, 49: 530-537.CrossRefPubMed

11.

Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennet ED: Pathophysiology of septic encephalopathy: a review. Crit Care Med 2000, 28: 3019-3024. 10.1097/00003246-200008000-00057CrossRefPubMed

12.

Bolton CF, Young GB, Zochodne DW: The neurological complications of sepsis. Ann Neurol 1993, 33: 94-100.CrossRefPubMed

13.

Freund HR, Muggia-Sullam M, Peiser J, Melamed E: Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. J Surg Res 1985, 38: 267-271. 10.1016/0022-4804(85)90037-XCrossRefPubMed

14.

Pendlebury WW, Perl DP, Munoz DG: Multiple microabscesses in the central nervous system: a clinicopathologic study. J Neuropathol Exp Neurol 1989, 48: 290-300.CrossRefPubMed

15.

Miller CF, Breslow MJ, Shapiro RM, Traystman RJ: Role of hypotension in decreasing cerebral blood flow in porcine endotoxemia. Am J Physiol 1987, 253: H956-H964.PubMed

16.

Moulin GC, Paterson D: E. coli peritonitis and bacteremia cause increased blood–brain barrier permeability. Brain Res 1985, 340: 261-268. 10.1016/0006-8993(85)90922-9CrossRefPubMed

17.

Bogdansky R, Blobner M, Becker I, Hänel F, Fink H, Kochs E: Cerebral histopathology following portal venous infusion of bacteria in a chronic porcine model. Anesthesiology 2000, 93: 793-804. 10.1097/00000542-200009000-00029CrossRef

18.

van den Brink WA, Marmarou A, Avezaat CJ: Brain edema in experimental closed head injury in the rat. Acta Neurochir Suppl 1990, 55: 261-262.

19.

Shapira Y, Setton D, Artru AA, Shohami E: Blood–brain barrier permeability, cerebral edema, and neurologic function after closed head injury in rats. Anesth Analg 1993, 77: 141-148.PubMed

20.

Okiyama K, Smith DH, Gennarelli TA, Simon RP, Leach M, McIntoch TK: The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem 1995, 64: 802-809.CrossRefPubMed

21.

Clawson CC, Hartmann JF, Vernier RL: Electron microscopy of the effect of gram-negative endotoxin on the blood–brain barrier. J Comp Neurol 1966, 127: 183-198.CrossRefPubMed

22.

Jeppson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE: Blood–brain barrier derangement in sepsis: cause of septic encephalopathy? Am J Surg 1981, 141: 136-141. 10.1016/0002-9610(81)90026-XCrossRef

23.

Deng X, Wang X, Anderrson R: Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol 1995, 78: 2052-2061.PubMed

24.

Oppelt WW, MacIntyre I, Rall DP: Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963, 205: 959-962.PubMed

25.

Ustun ME, Gurbilek M, Ak A, Vatansev H, Duman A: Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med 2001, 27: 264-268. 10.1007/s001340000780CrossRefPubMed

26.

Heath DL, Vink R: Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther 1999,288(3):1311-1316.PubMed

27.

Arnold A, Tovey J, Mangat P, Penny W, Jacobs S: Magnesium deficiency in critically ill patients. Anaesthesia 1995, 50: 203-205.CrossRefPubMed

28.

Bareyre FM, Saatman KE, Helfaer MA, Sinson G, Weisser JD, Brown AL, McIntosh TK: Alterations in ionized and total blood magnesium after experimental traumatic brain injury: relationship to neurobehavioral outcome and neuroprotective efficacy of magnesium chloride. J Neurochem 1999, 73: 271-280. 10.1046/j.1471-4159.1999.0730271.xCrossRefPubMed

Title: Effect of magnesium sulfate administration on blood–brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study
Authors: Figen Esen
Tulin Erdem
Damla Aktan
Mukadder Orhan
Mehmet Kaya
Haluk Eraksoy
Nahit Cakar
Lutfi Telci
Publication date: 01-02-2004
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2005
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc3004

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effect of magnesium sulfate administration on blood–brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study

Abstract

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2005

Dantrolene and heatstroke: a good molecule applied in an unsuitable situation

Bench-to-bedside review: Ethical challenges for those in directing roles in critical care units

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

Bench-to-bedside review: Permissive hypercapnia

Science review: The brain in sepsis – culprit and victim

Clinical review: Vasculitis on the intensive care unit – part 1: diagnosis